Search

Your search keyword '"Huland, Hartwig"' showing total 2,517 results

Search Constraints

Start Over You searched for: Author "Huland, Hartwig" Remove constraint Author: "Huland, Hartwig"
2,517 results on '"Huland, Hartwig"'

Search Results

1. Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death

2. Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy

3. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

5. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer

6. Radical prostatectomy in patients aged 75 years or older: review of the literature

7. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.

8. CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo

9. Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes.

10. Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy

11. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer—Translational Research Results from the Prospective ProMPT trial

15. Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups

17. High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

19. Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

20. Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions

22. Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

27. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

29. Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer

31. Therapie bei isoliertem PSA-Anstieg

35. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

36. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

37. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

38. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

39. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

40. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

41. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

42. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

43. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

44. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

45. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

48. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer

50. PD27-03 NERVE-SPARING RADICAL PROSTATECTOMY (NSRP) USING THE NEUROSAFE TECHNIQUE IS ONCOLOGICALLY SAFE: RESULTS AFTER 20 YEARS OF EXPERIENCE

Catalog

Books, media, physical & digital resources